Omicron Booster Dose
-
{
- All
- News
- Videos
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Australia Approves Covid Vaccine Boosters For 16- And 17-Year-Olds
Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
Covaxin Booster Enhances Protection Against Variants Of Concern: ICMR Study
A booster dose of Covaxin administered six months after the two dose primary vaccination has shown elevated immune responses against SARS-CoV-2 variants of concern including Omicron, a study by ICMR and Bharat Biotech has found.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Oil Prices Plunge As Omicron's Rapid Spread Dims Fuel Demand Outlook
Oil prices fell despite Moderna Inc's announcement on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against Omicron in laboratory testing.
-
Australia Approves Covid Vaccine Boosters For 16- And 17-Year-Olds
Australia's drug regulator on Friday approved the use of COVID-19 vaccine booster shots for 16- and 17-year-olds as authorities urge people to get their third doses soon to mitigate the threat from the Omicron coronavirus variant.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Covid Vaccine Booster Gives Effective Antibody Protection Against Omicron: Study
A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.
